Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmpeak Energy Regulatory News (AMP)

Share Price Information for Ampeak Energy (AMP)

Share Price is delayed by 15 minutes
Get Live Data
2.70    0.10 (3.85%)
Bid:
2.50
Ask:
2.90
Spread: 0.40 (16.00%)
Market Cap: £19.57m
AMP Live PriceLast checked at - London Stock Exchange

Intraday Ampeak Energy Share Chart

Additional Investments

3 Jan 2006 07:01

Amphion Innovations PLC03 January 2006 Amphion Innovations PLC Additional Investment in Portfolio Companies 3 January 2006 - Amphion Innovations PLC ("Amphion"), the developer oftechnology and life sciences businesses, today announces that it has completedadditional investments in its existing portfolio companies amounting to $2.23million. An additional $500,000 has been invested in Motif Biosciences Inc. ("Motif") aspart of an ongoing Series B financing. Motif is a population genetics companyworking to identify the genetic causes of major diseases by working with aunique, rich, and defensible source of human genetic data from the Persian Gulfstates. An additional $750,000 has been invested in AXCESS International, Inc. ("Axcess") (AXSI.OB) as part of an ongoing financing. Axcess provides radiofrequency identification (RFID) systems for physical security and supply chainefficiencies. An additional $980,000 has been invested in FireStar Software, Inc. ("FireStar")as part of an ongoing Series E financing. FireStar is a software company thathelps institutions achieve efficiency in their business transactions with theirclients. FireStar's flagship product EdgeNode is a complete interface solutionfor automating business transactions between companies. It is designed tosupport the unique needs of multi-enterprise process integration. These follow-on investments, made in line with Amphion's strategy as outlinedprior to its August 2005 admission to AIM, follow significant milestonesachieved by each of its portfolio companies: • Motif has signed a Letter of Intent with the leading private hospital network in the United Arab Emirates (UAE); filed a provisional patent covering its research; hired a leading population geneticist and additional scientific staff, and completed three years of research and development work in the US and Gulf prior to beginning its sampling program in 2006. • Axcess announced its 4Q2005 revenue (calendar) would be significantly higher than 3Q2005, based upon the rapid increase in awareness of RFID following a WalMart supplier mandate. Axcess announced its turn-key Asset ActivatorTM RFID system for automatically locating, counting, and protecting enterprise assets such as IT equipment, test equipment, etc. Axcess' "semi-active" tag activation methodology was widely publicized in the trade press as the next wave RFID solution for enterprise tagging of personnel, assets and vehicles of all kinds, further supported by a fourth patent award. Axcess has also discussed in general terms a revolutionary new RFID product it plans to announce in detail and begin selling in 2006. • FireStar has announced the release of EdgeNode, a software product designed to simplify the integration of back-office transactions between multiple enterprises. FireStar also booked its first customer for EdgeNode and filed a broad patent for the technology, with detail examples of 17 different applications. FireStar continues to make good progress in its other market development and distribution efforts. Additionally, Raymond Mackenzie, formerly of Lazard Freres and Morgan Stanley, has been named to the Board of Directors. Richard C. E. Morgan, CEO of Amphion, said: "Since Amphion's IPO in the summerof 2005, each of these portfolio companies has made strong progress. As such,we are confident in the outlook for each business and are therefore increasingour investment in all three companies." For More Information: Financial Dynamics +44 (0) 20 7831 3113Ben Atwell / John Gilbert Amphion InnovationsBen Austin 1 (917) 686-3979baustin@amphionplc.com About Amphion Amphion Innovations plc recently listed on the AIM Exchange in London under thesymbol AMP. Amphion's business is the formation, financing, management anddevelopment of life science and technology companies, working in partnershipwith corporations, governments, universities, and entrepreneurs seeking tocommercialize their intellectual property. On the Web: www.amphionplc.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
5th Sep 20187:00 amRNSBoard Change
23rd Aug 20183:20 pmRNSPolarean update
21st Aug 20187:15 amRNSMotif Bio notes statement from Amphion Innovations
21st Aug 20187:00 amRNSSale of Partner Company Shares
1st Aug 20184:47 pmRNSResult of AGM
29th Jun 20187:00 amRNSDirectorate Change
26th Jun 20187:00 amRNSFinal Results
23rd May 20187:00 amRNSMotif Bio notes statement from Amphion Innovations
23rd May 20187:00 amRNSSale of Partner Company Shares
20th Apr 20187:00 amRNSDirectorate Change
29th Mar 20187:00 amRNSAIM Admission & First Day of Dealings
29th Mar 20187:00 amRNSUpdate on Polarean Imaging IPO
26th Mar 20187:31 amRNSUpdate on Polarean Imaging proposed AIM IPO
2nd Mar 20187:00 amRNSConvertible promissory note extended to December
10th Jan 20185:09 pmRNSDirector dealing
22nd Dec 20177:01 amRNSComment on Polarean Fund Raise
22nd Dec 20177:00 amRNSRestructure of Loan and Additional Drawdown
5th Dec 20177:00 amRNSIssue of Shares
23rd Nov 20177:00 amRNSFurther Update on Polarean Imaging Limited
10th Nov 20177:00 amRNSUpdate on Polarean Imaging Limited
2nd Nov 20177:00 amRNSOrder Dismissing DataTern Case
11th Oct 20177:00 amRNSRelated Party Transaction
5th Oct 20177:00 amRNSPartner Company releases positive clinical results
29th Sep 20177:00 amRNSHalf-year Report
25th Sep 20177:01 amRNSHolding(s) in Company
25th Sep 20177:00 amRNSSale of Partner Company Shares
30th Aug 20177:00 amRNSSale of partner company shares
30th Aug 20177:00 amRNSHolding(s) in Company
1st Aug 20175:19 pmRNSAGM Statement
28th Jun 20177:00 amRNSFinal Results
31st May 20177:00 amRNSPartner Company m2m Imaging merger update
22nd May 20174:36 pmRNSAdditional Draw Down on Loan Facility
7th Feb 20177:00 amRNSAdditional Draw Down on Loan Facility
1st Feb 20175:18 pmRNSHolding(s) in Company
30th Dec 20162:38 pmRNSHolding(s) in Company
16th Dec 20163:07 pmRNSDirector/PDMR Shareholding
9th Dec 20163:50 pmRNSDirector/PDMR Shareholding
24th Nov 20162:15 pmRNSHolding(s) in Company
8th Sep 20167:00 amRNSRe-negotiated terms of Motif CPN
7th Sep 20167:00 amRNSInterim Results for the six months to 30 June 2016
22nd Aug 20163:58 pmRNSAdditional Draw Down on Loan Facility
3rd Aug 20164:13 pmRNSHolding(s) in Company
29th Jul 20167:00 amRNSResults of AGM and Directorate Change
18th Jul 20164:33 pmRNSTransfer of Shares
13th Jul 20167:01 amRNSNotice of Intention to List on NASDAQ by Motif Bio
13th Jul 20167:00 amRNSAdditional Draw Down on Loan Facility
23rd Jun 20167:00 amRNSFinal Results
29th Apr 20164:02 pmRNSAdditional Terms on Loan Facility
28th Apr 20167:00 amRNSAdditional Draw Down on Loan Facility
7th Apr 20167:00 amRNSAmphion settles contested arbitration ruling

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.